retatrutide clinical trials efficacy Looking forward to when #retatrutide's Phase 3 trial results will become available. There are are 4 planned TRIUMPH investigating retatrutide's in treating obesity and its complications: #type2diabetes #cardiovascular disease This weight-loss drug hasn't been

Because tirzepatide can be more potent for appetite suppression and weight loss, dose selection and escalation are especially important

Factors that can influence semaglutide dosage include age, sex, hormonal status, body weight, kidney function, presence of comorbidities, concurrent medications, tolerance to medication side effects, and lifestyle factors

Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice

J Pharmacol Toxicol Methods

My stomach felt off most mornings and certain foods made me queasy